Are US oncologists using genetic information to make treatment decisions? ISR’s Personalized Medicine’s Effect on Oncologists’ Treatment Regimens report indicates that many are and surprisingly, that practice setting and level of experience makes a big difference.
The data behind this report reveal how familiar US-based, board-certified oncologists are with personalized medicine, how they are treating patients, what tests are being used, and how their patient treatment regimens could evolve in the future.
This report will help you learn:
- What percentage of patients are requesting personalized treatments vs. the percentage of oncologists suggesting them
- Which genetic tests oncologists perform and how the data are used and stored for use in future clinical trials
- What is preventing more widespread use of genetic testing
- The impact personalized medicines have on oncologists’ participation in clinical trials